NewEdge Advisors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
NewEdge Advisors's ADPT Position: Q3 2026 in Review
NewEdge Advisors opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 117 shares worth $3.38K. The stake represents ﹤0.01% of the portfolio and ranks #3887 among its holdings. This is a return to the name: NewEdge Advisors previously reported a position in ADPT as recently as Q3 2025.
NewEdge Advisors first reported a position in ADPT in Q4 2022 and has held it in 13 quarters since. The position peaked at $84K in Q1 2023. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- NewEdge Advisors held 117 shares of Adaptive Biotechnologies worth $3.38K as of Q3 2026.
- Adaptive Biotechnologies was a new NewEdge Advisors position in Q3 2026.
- Adaptive Biotechnologies made up ﹤0.01% of NewEdge Advisors's portfolio in Q3 2026, its #3887 holding.
- NewEdge Advisors first reported a position in Adaptive Biotechnologies in Q4 2022 and has held it in 13 quarters since.
- NewEdge Advisors's Adaptive Biotechnologies position peaked at $84K in Q1 2023.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on NewEdge Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.